[HTML][HTML] Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy
L Ojeda-Fernández, M Baviera, A Foresta… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background COVID-19 has been associated with a higher risk of post-acute complications.
Our aim was to analyze and compare post-acute cardiovascular complications of COVID-19 …
Our aim was to analyze and compare post-acute cardiovascular complications of COVID-19 …
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study
E Corneo, R Garbelotto, G Prestes, CS Girardi… - Thrombosis …, 2023 - Springer
Background Because severe acute respiratory syndrome coronarivus 2 (SARS-CoV-2)
leads to severe conditions and thrombus formation, evaluation of the coagulation markers is …
leads to severe conditions and thrombus formation, evaluation of the coagulation markers is …
Accelerated LVAD pump thrombosis in COVID‐19 patient: Case report and mini review
Abstract Background Coronavirus (COVID‐19) infection exposes patients with heart failure
specially who are on mechanical support to a higher risk of morbidity and mortality. Aims To …
specially who are on mechanical support to a higher risk of morbidity and mortality. Aims To …
Changes in life expectancy and life span equality during the COVID-19 epidemic in Japan up to 2022
Y Okada, H Nishiura - medRxiv, 2024 - medrxiv.org
Objectives: To evaluate the impact of COVID-19 on life expectancy in Japan through
demographic analyses. Methods: We evaluated the relationship between the life expectancy …
demographic analyses. Methods: We evaluated the relationship between the life expectancy …
Intracardiac Thrombus in COVID-19 Inpatients: A Nationwide Study of Incidence, Predictors, and Outcomes
COronaVIrus Disease-2019 (COVID-19) is associated with a hypercoagulable state.
Intracardiac thrombosis is a potentially serious complication but has seldom been evaluated …
Intracardiac thrombosis is a potentially serious complication but has seldom been evaluated …
[HTML][HTML] High-risk subgroups were not identified to benefit from thromboprophylaxis after hospitalization for COVID-19
LB Kreuziger, T Kwon, RS Kasthuri, L Wahid… - Research and Practice …, 2024 - Elsevier
Abstract Background The Accelerating COVID-19 Therapeutic Interventions and Vaccines-
4c (ACTIV-4c) trial investigated prophylactic apixaban for 30 days following hospitalization …
4c (ACTIV-4c) trial investigated prophylactic apixaban for 30 days following hospitalization …
[HTML][HTML] Clinical characteristics of stroke in SARS-CoV-2 infected patients in Japan: A prospective nationwide study
Y Nishiyama, S Miyamoto, M Sakaguchi… - Journal of the …, 2024 - Elsevier
Introduction We investigated the clinical characteristics and outcomes of stroke in SARS-
CoV-2 infected patients in Japan. Methods This prospective, multicenter observational study …
CoV-2 infected patients in Japan. Methods This prospective, multicenter observational study …
COVID-19-ассоциированный тромбоз: какие новые знания и проблемы тромботических осложнений обозначила пандемия?
ПГ Мадонов, АП Момот, ЕВ Ройтман… - Тромбоз, гемостаз и …, 2023 - thrj.ru
Отличительной чертой новой коронавирусной инфекции (НКИ) COVID-19
является быстрое развитие коагулопатии с формированием тромбозов, которые …
является быстрое развитие коагулопатии с формированием тромбозов, которые …
Thymidine Phosphorylase Mediates SARS-CoV-2 Spike Protein Enhanced Thrombosis in K18-hACE2TG Mice
R Roytenberg, H Yue, A DeHart, E Kim, F Bai, Y Kim… - bioRxiv, 2024 - biorxiv.org
COVID-19, caused by SARS-CoV-2, is associated with arterial and venous thrombosis,
thereby increasing mortality. SARS-CoV-2 spike protein (SP), a viral envelope structural …
thereby increasing mortality. SARS-CoV-2 spike protein (SP), a viral envelope structural …
[HTML][HTML] 静脉血栓栓塞相关危险因素的研究进展
罗臻， 郭伟， 王敏 - Advances in Clinical Medicine, 2023 - hanspub.org
静脉血栓栓塞(VTE) 是全球第三大常见死亡原因. 不同国家的静脉血栓栓塞的发生率不同.
在发生静脉血栓栓塞的患者中, 已经发现了许多危险因素, 但每个危险因素对血栓形成风险的 …
在发生静脉血栓栓塞的患者中, 已经发现了许多危险因素, 但每个危险因素对血栓形成风险的 …